Evaluating therapeutic modalities for prevention and treatment of postmenopausal osteoporosis.
Sagraves
Rosalie
R
College of Pharmacy, University of Illinois at Chicago, 833 S. Wood St., Chicago, IL 60612-7230, USA. sagraves@uic.edu
D019587:Dietary Supplements; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000150:complications / Q000191:economics / Q000517:prevention & control; D020249:Hormone Replacement Therapy; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D009316:National Institutes of Health (U.S.); D015663:Osteoporosis, Postmenopausal / Q000150:complications / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control*; D045167:Progesterone Congeners / Q000627:therapeutic use; D014481:United States; D016387:Women's Health
D004967:Estrogens; D045167:Progesterone Congeners; D017258:Medroxyprogesterone Acetate